< Back to previous page

Publication

Clinical benefit with ripretinib as >= 4th line treatment in patients with advanced gastrointestinal stromal tumors (GIST): Update from the phase III INVICTUS study

Journal Contribution - Journal Article Conference Contribution

Journal: ANNALS OF ONCOLOGY

ISSN: 0923-7534

Volume: 31

Pages: S973 - S974

Publication year:2020

Institutional Repository URL: https://lirias.kuleuven.be/3261999
DOI: https://doi.org/10.1016/j.annonc.2020.08.1848
WoS Id: 000573469102209